Jasper Therapeutics Launches Cash Tender Offer to Buy Back Outstanding Warrants

Key Facts

1Jasper Therapeutics commenced an offer to purchase all outstanding warrants issued in September 2025 for $0.324 in cash per warrant.

Jasper Therapeutics commenced an offer to purchase all outstanding warrants issued in September 2025 for $0.324 in cash per warrant. GlobeNewswire reported that the company initiated this tender offer to buy back and cancel the warrants as part of an effort to simplify its capital structure.

The company aims to reduce potential share dilution and provide investors with more certainty regarding its capital structure by retiring these instruments. JSPR closed at $0.5601 on October 6, 2026, prior to the announcement of this cash offer intended to streamline the clinical-stage biotech's equity base.